Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Change in Accured Expenses (2016 - 2025)

Idex (IEX) has disclosed Change in Accured Expenses for 17 consecutive years, with -$8.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 6.17% to -$8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 120.93% increase, with the full-year FY2025 number at $1.8 million, up 120.93% from a year prior.
  • Change in Accured Expenses was -$8.6 million for Q4 2025 at Idex, down from $32.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $35.6 million in Q3 2022 to a low of -$27.6 million in Q2 2023.
  • A 5-year average of $40000.0 and a median of -$3.0 million in 2024 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 417.3% in 2021, then plummeted 1093.33% in 2025.
  • Idex's Change in Accured Expenses stood at $6.9 million in 2021, then tumbled by 49.28% to $3.5 million in 2022, then crashed by 122.86% to -$800000.0 in 2023, then plummeted by 912.5% to -$8.1 million in 2024, then dropped by 6.17% to -$8.6 million in 2025.
  • Per Business Quant, the three most recent readings for IEX's Change in Accured Expenses are -$8.6 million (Q4 2025), $32.8 million (Q3 2025), and -$4.5 million (Q2 2025).